Literature DB >> 11302904

Drug points: Benign intracranial hypertension secondary to nasal fluticasone propionate.

D W Bond1, C P Charlton, R M Gregson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11302904      PMCID： PMC30587          DOI： 10.1136/bmj.322.7291.897

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Benign intracranial hypertension. A review of 79 cases in infancy and childhood.

Authors:  D N Grant
Journal:  Arch Dis Child       Date:  1971-10       Impact factor: 3.791

2.  Benign intracranial hypertension in a child with eczema treated with topical steroids.

Authors:  G P Hosking; H Elliston
Journal:  Br Med J       Date:  1978-03-04

3.  Steroid-induced benign intracranial hypertension.

Authors:  C K Vyas; K K Talwar; V Bhatnagar; B K Sharma
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

4.  Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease.

Authors:  M Newton; B T Cooper
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

5.  Benign intracranial hypertension following corticosteroid withdrawal in childhood.

Authors:  B G Neville; J Wilson
Journal:  Br Med J       Date:  1970-09-05
  5 in total
  2 in total

1.  Intracranial hypertension and nasal fluticasone propionate.

Authors:  M Oko; A Johnston; I R Swan
Journal:  BMJ       Date:  2001-09-22

Review 2.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.